
zzso variation in patients' experiences of involvement in treatment decision making can identify groups needing extra support, such as additional consultation time, when considering treatment zzso 

We zzso data from the 2010 English National Cancer Patient Experience Survey, a national survey of all patients attending hospitals in England for cancer treatment over a zzso period, to examine how experience of involvement in decisions about treatment varied between patients with 38 different primary zzso using zzso zzso We zzso responses from zzso patients to a single question examining patient experience of involvement in treatment decision zzso We calculated zzso odds ratios of reporting the most positive experience between patients of different zzso and zzso characteristics and explored the effects of adjusting for age, zzso ethnicity, zzso cancer type and hospital of zzso 

Of the zzso zzso zzso zzso reported positive experiences of decision-making zzso Younger patients reported substantially less positive experiences of involvement in decision making zzso zzso zzso vs zzso zzso as did ethnic minorities zzso zzso zzso and zzso for Black, Chinese and Asian vs White patients, zzso zzso Experience varied considerably between patients with different zzso ( zzso zzso for zzso and zzso for melanoma vs colon zzso zzso with zzso zzso zzso and zzso cancer patients reporting substantially worse experiences compared with other patients with zzso zzso zzso and zzso zzso zzso zzso of different patient groups within hospitals with outlying performance report scores could not account for observed zzso 

Efforts to improve involvement in treatment decision making can focus on those who report the worst experience, in particular younger patients, ethnic minorities and patients with zzso zzso multiple myeloma and zzso zzso 

